Janux Therapeutics Inc (JANX)
48.79
+2.29
(+4.92%)
USD |
NASDAQ |
Nov 22, 14:36
Janux Therapeutics Net Income (Quarterly): -28.06M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -28.06M |
June 30, 2024 | -5.959M |
March 31, 2024 | -14.76M |
December 31, 2023 | -11.76M |
September 30, 2023 | -11.57M |
June 30, 2023 | -17.51M |
March 31, 2023 | -17.46M |
December 31, 2022 | -16.06M |
September 30, 2022 | -16.70M |
June 30, 2022 | -16.89M |
Date | Value |
---|---|
March 31, 2022 | -13.41M |
December 31, 2021 | -13.42M |
September 30, 2021 | -10.77M |
June 30, 2021 | -6.206M |
March 31, 2021 | -2.284M |
December 31, 2020 | -1.655M |
September 30, 2020 | -1.256M |
June 30, 2020 | -2.46M |
March 31, 2020 | -1.413M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-28.06M
Minimum
Sep 2024
-1.256M
Maximum
Sep 2020
-11.03M
Average
-11.76M
Median
Dec 2023
Net Income (Quarterly) Benchmarks
Dynavax Technologies Corp | 17.59M |
Krystal Biotech Inc | 27.18M |
NovaBay Pharmaceuticals Inc | -1.212M |
Palatin Technologies Inc | -7.824M |
iBio Inc | -3.989M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 0.439M |
Total Expenses (Quarterly) | 36.28M |
EPS Diluted (Quarterly) | -0.51 |
Enterprise Value | 1.782B |
Profit Margin (Quarterly) | -6.39K% |
Earnings Yield | -2.38% |
Normalized Earnings Yield | -2.378 |